Orelabrutinib
Orelabrutinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Orelabrutinib is under investigation in clinical trial NCT04305197 (A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)).
| Trade Name | Orelabrutinib |
| Generic | Orelabrutinib |
| Orelabrutinib Other Names | Orelabrutinib |
| Type | |
| Formula | C26H25N3O3 |
| Weight | Average: 427.504 Monoisotopic: 427.189591677 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Orelabrutinib
